ARRB2 and epilepsy: Polymorphisms in ARRB2 have been associated with μ-opiod receptor sensitivity14 and perceived breathlessness in patients receiving opiods.15 Additional potentially pathogic variants and variants of unknown signficance (VUS) occurred in genes associated with epilepsy/SUDEP that were unique to individual subjects.